Powerup Acquisition Stock Price, News & Analysis

PowerUp Acquisition Corp. (PWUPU) is a blank check company whose units traded on the Nasdaq Global Market under the ticker symbol PWUPU. According to company disclosures, it was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Its focus, as described in its public offering materials, has been on opportunities in interactive media, digital media, sports, entertainment and leisure, with particular attention to video gaming, gaming-adjacent businesses and new metaverse video gaming businesses.

The PWUPU symbol represents units that were offered in an initial public offering. Each unit consisted of one Class A ordinary share and one-half of one warrant. As disclosed in the company’s press releases, each whole warrant entitled the holder to purchase one Class A ordinary share at a specified exercise price. The units began trading on Nasdaq under PWUPU, with the Class A ordinary shares and redeemable warrants expected to trade separately under the symbols PWUP and PWUPW once the securities comprising the units began separate trading.

PowerUp Acquisition Corp. described itself in its offering documents and related announcements as a special purpose vehicle intended to identify and acquire one or more operating businesses. The stated objective was to complete a business combination, often referred to in this context as an initial business combination, with targets in sectors such as interactive media and digital entertainment. As a blank check company, its initial activities centered on capital raising through its unit offering and the subsequent search for suitable business combination candidates, rather than operating an existing commercial business.

Subsequent regulatory filings indicate that the corporate entity associated with this listing is now named Aspire Biopharma Holdings, Inc. Filings on Form 8-K refer to Aspire Biopharma Holdings, Inc. as the registrant, with PowerUp Acquisition Corp. identified as a former name or former address. These filings show that the company is incorporated in Delaware and that its common stock trades under the symbol ASBP on The Nasdaq Stock Market LLC. The disclosures describe Aspire Biopharma Holdings, Inc. as an emerging growth company.

Later Form 8-K filings for Aspire Biopharma Holdings, Inc. describe corporate and financing developments. One filing reports that the company entered into a Securities Purchase Agreement with certain investors, under which it issued notes with an original issue discount that are convertible into common stock at a conversion price based on a percentage of recent trading prices. The filing explains that the notes were offered in reliance on an exemption from registration under the Securities Act of 1933 and that the company agreed to a registration rights arrangement to register the resale of the common stock underlying the notes.

Another Form 8-K filing discusses changes in the company’s leadership and board composition. It notes the resignation of a chief executive officer and director, the appointment of an interim chief executive officer, and changes among independent directors and the audit committee chair. The same filing identifies PowerUp Acquisition Corp. as a former name or former address of the registrant, reinforcing the continuity between the blank check company and Aspire Biopharma Holdings, Inc. as reflected in SEC records.

A further Form 8-K filing records a change in the company’s principal executive office location, indicating that Aspire Biopharma Holdings, Inc. moved its principal executive office and headquarters to a location in Estero, Florida. The filing lists the company’s jurisdiction of incorporation as Delaware and confirms that its common stock, with a stated par value per share, is registered and traded under the ASBP symbol on Nasdaq.

For investors reviewing the history of PWUPU, these disclosures show that the units were associated with a special purpose acquisition company that later appears in SEC filings under the Aspire Biopharma Holdings, Inc. name and the ASBP trading symbol. The available information focuses on the structure of the unit offering, the intended business combination strategy in interactive and digital media-related sectors, and subsequent corporate actions and financings disclosed after the transition to Aspire Biopharma Holdings, Inc.

Business focus and structure

According to its offering-related announcements, PowerUp Acquisition Corp. was organized to pursue a business combination rather than to operate an existing line of business. Its stated sector focus was on interactive media, digital media, sports, entertainment and leisure, with particular emphasis on video gaming and metaverse-related gaming businesses. This focus guided the search for potential acquisition or merger targets, as described in its public communications.

The unit structure disclosed in its press releases combined equity and warrants. Each unit included one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable for one Class A ordinary share at a specified exercise price. The company also described the placement of offering proceeds and private placement proceeds into a trust account, as is typical for blank check companies, with an audited balance sheet to be filed on Form 8-K to reflect receipt of proceeds.

Corporate evolution reflected in SEC filings

Later SEC filings under the name Aspire Biopharma Holdings, Inc. show that the registrant continues as a Delaware corporation, with its common stock listed on Nasdaq under the symbol ASBP. These filings document corporate events such as changes to the principal executive office location, board and management transitions, and the execution of financing agreements involving convertible notes and related registration rights. They also identify PowerUp Acquisition Corp. as a former name or address, indicating that the entity associated with the PWUPU units has undergone a name or structural change as reflected in the SEC record.